Clinical Trials Browser

Adenocarcinoma, Carcinoma, Adenocarcinoma, Mucinous, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Rectal Diseases, Rectal Neoplasms, Colorectal Neoplasms, Neoplasms, Cystic, Mucinous, and Serous

NCT03672136 2018-09-14

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

Phase 2 Unknown

25 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03588494 2018-07-17

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Phase 2/3 Unknown

318 enrolled

Quality of Life

NCT03579004 2018-07-06

Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

Phase 2 Unknown

48 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Esophageal Neoplasms

NCT03177382 2018-05-08

TNTCRT

Phase 3 Unknown

458 enrolled

Gastrointestinal

Rectal Neoplasms

NCT03468010 2018-03-26

A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)

Phase 3 Unknown

432 enrolled

Gynecologic

Uterine Cervical Neoplasms, Lymphatic Metastasis

NCT03424291 2018-02-06

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Phase 2 Unknown

60 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT03366883 2018-01-09

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

Phase 3 Unknown

420 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT03045484 2017-11-29

Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy

Phase NA Unknown

70 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03274284 2017-09-11

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer

Phase 4 Unknown

20 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT02439593 2017-08-01

HEATPAC

Phase 2 Unknown

78 enrolled

Gastrointestinal

Hyperthermia, Pancreatic Neoplasms

NCT03225963 2017-07-24

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

Unknown

60 enrolled

CNS

Glioblastoma

NCT02734680 2017-04-11

IFCSLAPC

Phase NA Unknown

70 enrolled

Gastrointestinal

Pancreatic Neoplasms

NCT03058432 2017-02-23

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Phase 2 Unknown

122 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT02798510 2016-06-22

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

Phase 3 Unknown

140 enrolled

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT02505672 2016-04-19

Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma

Unknown

50 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT01551641 2016-02-17

Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer

Phase 2 Unknown

180 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT01074021 2015-10-30

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer

Phase 3 Unknown

480 enrolled

Head & Neck

Nasopharyngeal Neoplasms

Clinical Trials

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery

ESTIMATE

Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?

Prediction Model of Response for CCRT in Esophageal Cancer

PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial

Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma

RACE-GB

Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients

PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer

Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy

Phase II Study of DC Versus 5-FU/CF as Chemotherapy and Concurrent Chemoradiotherapy for Locally Advanced Gastric Cancer

Hypofractionated Chemoradiotherapy and Thymosin α1 in Unresectable or Recurrent Thymic Epithelial Tumor

Study to Nivolumab Following Preoperative Chemoradiotherapy

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

A Trial of Neoadjuvant mFOLFOXIRI Versus CRT in the EMVI Positive LARC

Role of Hypofractionated Radiotherapy With Concurrent Gemcitabine in Treatment of Urinary Bladder Carcinoma

High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer

Total Neoadjuvant Therapy in Rectal Cancer Treatment

High Dose Radiation Therapy With Concurrent Chemotherapy in Locally Advanced Non-small Cell Lung Cancer

A Multicenter, Prospective, Phase III Randomized Controlled Clinical Study for the Treatment of N2-3 Nasopharyngeal Carcinoma Patients

OITROLC

Toripalimab in Combination With Chemotherapy as Induced Chemotherapy for Localized Hypopharyngeal Cancer

Study of Endostar Combined With TP Regimen for Esophageal Cancer

INDUCTION

NAC Followed by RH for the Treatment of LACC

Organ Preservation in Elderly Patients With Rectal Cancer

CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC

Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

Endostar in Combination With Chemoradiotherapy in Patient With Advanced Non-small Cell Lung Cancer

Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

TNTCRT

A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)

A Retrospective Clinical Study of Apatinib in Combination With Radiotherapy / Chemotherapy Second-line and Above in the Treatment of Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma

Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESC

Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy

Chemoradiotherapy for Recurrent T1G3 Bladder Cancer

HEATPAC

Application of Proteome Profiler Antibody Arrays to Find Angiogenetic Predictors in Glioma Paitents.

IFCSLAPC

Concurrent Chemotherapy for Elderly Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma

Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer

Nimotuzumab in Combination With Chemoradiation for Nasopharyngeal Cancer